Business SK bioscience secures additional PAHO contract to supply varicella vaccines to Latin America
By Diplomacy Journal Lee Kap-soo SK bioscience announced on February 28 that it has successfully secured additional orders for its self-developed chickenpox vaccine in the largest international procurement market in Latin America. This order comes as a result of prior notification from the Pan American Health Organization (PAHO), a UN agency, to supply its chickenpox vaccine, 'SkyVaricella,' to the Latin American region through 2027. The order was secured during PAHO's preliminary bidding process, and depending on the volume of orders from PAHO, SK bioscience will supply the chickenpox vaccine